JAMA Oncology shared a post on X about a paper by Paul Cinciripini, Professor and Chair of the Department of Behavioral Science at MD Anderson Cancer Center:
“Most viewed in the last 7 days from JAMA Oncology:
In a study of over 4,500 cancer patients, those who quit smoking within 6 months of diagnosis through a cessation program showed the greatest survival benefit.”
“Survival Outcomes of an Early Intervention Smoking Cessation Treatment After a Cancer Diagnosis”
Authors:
More posts featuring JAMA Oncology.
Paul Cinciripini, PhD, is a clinical psychologist, Professor and Chair of the Department of Behavioral Science, and Director of the Tobacco Treatment Program at the University of Texas MD Anderson Cancer Center. He holds the Margaret & Ben Love Chair in Clinical Cancer Care in honor of Dr. Charles A. LeMaistre.
With a background in clinical psychology and psychophysiology, Dr. Cinciripini’s research focuses on developing innovative behavioral and pharmacological treatments for nicotine dependence and examining individual differences that influence treatment outcomes.
